Assessment and Management of Systemic Hypoperfusion in Adults

1. Definition and Recognition

• Systemic hypoperfusion (shock) is a life‑threatening condition that can occur even when arterial blood pressure is normal; diagnosis must rely on multiple perfusion markers rather than pressure alone. 1

2. Key Assessment Parameters

2.1 Clinical Perfusion Markers

• Capillary refill time (CRT) should be measured routinely as the primary bedside skin‑perfusion indicator. 1
• Skin temperature and mottling are useful adjuncts to CRT for early detection of hypoperfusion. 1

2.2 Laboratory Markers

• Blood lactate is the cornerstone laboratory marker for shock assessment. 1
• Modest lactate elevations above 2 mmol/L are associated with increased mortality. 1
• Serial lactate clearance and time to normalization predict outcomes more reliably than blood pressure alone. 1
• The cumulative lactate area‑under‑the‑curve over time correlates with organ failure and mortality risk. 1
• Targeting lactate reduction during resuscitation improves outcomes in septic shock. 1

2.3 Invasive Hemodynamic Monitoring (when central venous access is available)

• Central venous oxygen saturation (ScvO₂) should be measured serially to assess tissue oxygen extraction. 1
• The veno‑arterial CO₂ gradient (Pv‑aCO₂) should be monitored when both central venous and arterial catheters are in place. 1
• The ratio of Pv‑aCO₂ to the arteriovenous oxygen‑content difference may provide additional insight into microcirculatory adequacy. 1

3. Hemodynamic Characterization

• Arterial pressure waveforms help differentiate shock subtypes:
  
  • Vasodilatory (e.g., septic) shock shows low diastolic pressure with preserved pulse pressure. 1
  • Cardiogenic or hypovolemic shock shows low pulse pressure with relatively higher diastolic pressure. 1
• Across all shock types, systolic blood pressure and mean arterial pressure (MAP) tend to fall. 1

4. Resuscitation Strategy

4.1 Fluid Resuscitation

• Administer an initial crystalloid bolus of at least 30 mL/kg within the first 3 hours of recognizing sepsis‑related hypoperfusion (strong initial recommendation). 2
• Use balanced crystalloids or normal saline as first‑line fluids. 2
• Continue fluid challenges while MAP, lactate, and urine output improve. 2
• Add albumin when large volumes of crystalloid are required. 2
• Hydroxyethyl starches are contraindicated in sepsis. 2

4.2 Vasopressor Management

• Target an initial MAP ≥ 65 mm Hg; MAP 60–65 mm Hg is acceptable in older patients and may reduce vasopressor exposure. 2
• First‑line vasopressor: norepinephrine continuous infusion. 2
• Second‑line: vasopressin 0.03 U/min to raise MAP or lower norepinephrine dose. 2
• Third‑line/adjunct: epinephrine. 2
• Dopamine should be avoided except in highly selected low‑arrhythmia‑risk patients; low‑dose dopamine is never indicated for renal protection. 2
• Place an arterial catheter promptly in any patient requiring vasopressors for accurate pressure monitoring. 2

4.3 Source Control and Antimicrobials

• Identify and control the infectious source within 12 hours of sepsis diagnosis. 2
• Prefer the least invasive source‑control method (e.g., percutaneous drainage over surgery). 2
• Remove infected intravascular devices promptly after establishing alternative access. 2
• Initiate broad‑spectrum antibiotics immediately when sepsis is suspected. 2

4.4 Adjunctive Therapies

• Corticosteroids – Do not give routine hydrocortisone if adequate fluid and vasopressor therapy achieve hemodynamic stability; consider a continuous infusion of 200 mg/day only when stability cannot be attained; never use steroids for sepsis without shock. 2
• Transfusion – Apply a restrictive strategy (transfuse when hemoglobin < 7 g/dL) after hypoperfusion resolves; in concurrent acute brain injury or hypoxic‑ischemic encephalopathy, higher hemoglobin targets may be appropriate. 2

5. Critical Pitfalls to Avoid

• Do not rely solely on blood pressure; normal pressure does not exclude severe hypoperfusion. 1
• Do not assume that improvements in macrocirculatory variables (pressure, cardiac output) guarantee microcirculatory recovery; continue monitoring tissue‑perfusion markers. 1

6. Ongoing Management

• Serial reassessment of all perfusion markers (lactate clearance, skin perfusion, ScvO₂) is essential to gauge shock evolution and treatment adequacy; persistent abnormalities should trigger escalation of therapy. 1

Systemic Hypoperfusion: Definition, Clinical Features, and Assessment

Definition and Pathophysiology

• Systemic hypoperfusion is a life‑threatening acute circulatory failure in which reduced tissue perfusion leads to inadequate oxygen delivery or utilization, causing cellular dysoxia and subsequent organ dysfunction. 3
• Cellular dysoxia is reflected by elevated blood lactate concentrations, typically exceeding 2 mmol/L. 3
• Inadequate tissue perfusion can involve multiple organ systems despite the presence of compensatory mechanisms. 3

Clinical Presentation

• The syndrome commonly presents with hypotension, tachycardia, and observable signs of inadequate perfusion in readily accessible organs. 3
• Skin findings: prolonged capillary refill time, cool extremities, and mottling indicate abnormal cutaneous perfusion. 3
• Renal findings: reduced urine output (approximately <0.5 mL/kg/h) signals impaired renal perfusion. 3
• Neurologic findings: altered mental status or decreased level of consciousness reflect cerebral hypoperfusion. 3
• Normal arterial blood pressure does not exclude severe tissue hypoperfusion; hypotension is frequent but not mandatory for the diagnosis. 3

Laboratory Marker

• A lactate level >2 mmol/L is the cornerstone laboratory indicator of systemic hypoperfusion. 3

Hemodynamic Patterns Underlying Systemic Hypoperfusion

• Four primary hemodynamic patterns can give rise to systemic hypoperfusion:
  These patterns are frequently mixed; for example, septic shock often combines myocardial depression with distributive features. 3

Assessment Strategy

Multimodal Monitoring

• Serial assessment of tissue perfusion should employ multiple bedside and invasive parameters rather than relying on a single variable. 4
• Capillary refill time (CRT): primary bedside skin‑perfusion indicator, supplemented by skin temperature and mottling assessment. 4
• Serial lactate measurements: guide resuscitation efforts and evaluate adequacy of tissue perfusion. 4
• Central venous oxygen saturation (ScvO₂): useful when central venous access is available. 4
• Veno‑arterial CO₂ gradient (Pv‑aCO₂): applicable when both central venous and arterial catheters are in place. 4

Therapeutic Principle

• Improvements in macrocirculatory variables (e.g., arterial pressure, cardiac output) do not necessarily translate into better regional or tissue perfusion; management must be directed by markers of peripheral/microcirculatory hypoperfusion rather than pressure alone. 4

ESICM 2025 Guidelines on Peripheral Perfusion Monitoring in Circulatory Shock

General Recommendations

• The 2025 ESICM guidelines on circulatory shock emphasize that peripheral perfusion markers should be routinely monitored to detect tissue hypoperfusion, even when central hemodynamic variables appear adequate. 5
• The guidelines advise a multimodal approach to tissue‑perfusion assessment, recommending that clinicians avoid reliance on arterial blood pressure alone for evaluating circulatory status. 5

Bedside Perfusion Markers

• Serial capillary refill time (CRT) is recommended as the primary bedside indicator of skin perfusion, with adjunctive use of skin temperature and mottling scores to improve detection of peripheral hypoperfusion. 5

Interpretation of Macro‑ vs. Microcirculatory Changes

• The ESICM statements caution that improvements in macrocirculatory parameters such as arterial pressure or cardiac output do not necessarily translate into restored microcirculatory perfusion, underscoring the need for direct peripheral perfusion monitoring. 5

Integration with Other Perfusion Indicators

• Perfusion index (PI) should be interpreted together with other guideline‑endorsed markers, including:

Practical Pitfalls and Cautions

• The guidelines warn that PI must not be used as the sole indicator of perfusion status; it should always be combined with clinical examination, vital signs, and the additional perfusion markers listed above. 5
• Universal PI thresholds should not be applied across all clinical scenarios; optimal cut‑points differ by condition (e.g., a PI < 1 may suggest hemorrhagic shock, whereas a PI ≈ 0.6 may be used for predicting return of spontaneous circulation during cardiac arrest). 5